Deleted Tweets From , -D.C.
's accounts: US_FDA
Tracking Since: October 16, 2019
On Wednesday, the FDA issued a constituent update to remind produce stakeholders of a prior statement regarding enforcement discretion for the agricultural water compliance dates. https://t.co/JxjM1Nohqe QT @FDAfood: Reminder for produce stakeholders: @US_FDA previously announced its intention to exercise enforcement discretion f… https://t.co/gims5vCXap)
We published several guidances focused on generic drug application submissions, labeling, and review. These guidances are part of the FDA’s continued efforts to bring greater efficiency and transparency to the generic drug review process. https://t.co/PbhRuhXRcl
We published an article discussing our commitment toward advancing two proposed tobacco product standards—one prohibiting menthol as a characterizing flavor in cigarettes and another prohibiting all characterizing flavors (including menthol) in cigars. https://t.co/qyhTSeWwLx QT @US_FDA: The agency remains on track to advance two proposed tobacco product standards—one prohibiting menthol as a characte… https://t.co/zw3TOu2ENx)
To help ensure Americans have access to compounded medicines when a patient’s needs cannot be met by an FDA-approved drug, we’ve added the first four bulk drug substances to the 503B Bulks List that may be used in compounding by outsourcing facilities. https://t.co/pqHKyztLKz
Today's “FDA Roundup” includes updates on another authorized OTC COVID-19 antigen test, updated In Vitro Diagnostics EUAs, a new drug approval, and info on two final guidances regarding medical device clinical studies. https://t.co/oN5KnHstvz https://t.co/2nMTsgF9UC
RT @FDA_Drug_Info: This week, FDA published a series of guidances focused on generic drug application submissions, labeling, and revie… https://t.co/aIq8unkq8P
As of today, 420 tests and sample collection devices are authorized by the FDA under emergency use authorizations (EUAs). These include 290 molecular tests and sample collection devices, 87 antibody and other immune response tests and 44 antigen tests.
On Jan. 14, we released a report on the investigation of the Salmonella Typhimurium outbreak that caused 31 reported illnesses and four hospitalizations in the U.S. between June and August 2021. https://t.co/EN4QJKxmIj QT @FrankYiannasFDA: FDA has released a report on its investigation of the Salmonella Typhimurium outbreak related to packaged salad gre… https://t.co/g8clLc1Bd9)
The @FDADeviceInfo Health of Women Program Strategic Plan is now available. https://t.co/vHoGEJHYqa
Today's “FDA Roundup” features the @FDADeviceInfo Health of Woman Program Strategic Plan and our investigational report on the Salmonella Typhimurium outbreak related to packaged salad greens in the U.S. between June and August 2021. https://t.co/si8EGWfDcs https://t.co/LLBCdFbgYK
How with the old, and in with the new in 2022? Don't forget to include your expired, unwanted, or unused medicines. https://t.co/kaQS7fhnBU #OrganizeYourHomeDay https://t.co/l2g3VNaacl
This is the second Listeria outbreak linked to packaged salads that the FDA and CDC are currently investigating. On Dec. 21, we announced a separate outbreak investigation linked to Fresh Express packaged salad. https://t.co/iBUciPWzDi
An IVC filter is a small cage-like device inserted into the largest vein in the body to capture blood clots and prevent them from traveling to the lungs.
Today we authorized marketing of the first laser-based device for the removal of Inferior Vena Cava (IVC) filters, designed to remove tissue to facilitate detachment of an IVC filter during retrieval when previous methods of removal have failed. https://t.co/QRXbBYvZAe https://t.co/ihwZbugRzp
As of today, 422 tests and sample collection devices are authorized by the FDA under emergency use authorizations (EUAs). These include 291 molecular tests and sample collection devices, 90 antibody and other immune response tests and 41 antigen tests.
FDA updated the SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests web page. The update added new information about the Meridian Bioscience, Inc. Revogene SARS-CoV-2 test, including the impact of the SARS-CoV-2 omicron variant on test performance. https://t.co/3fAqBTScxV
Here are several actions we’ve taken in our ongoing response to the #COVID19 pandemic. https://t.co/ig0UkP1zeU https://t.co/ykVSKr2bZt
Why should adults 18+ get a COVID vaccine booster? Because it gives you stronger protection from COVID and its variants. https://t.co/rVW7ZCsAyW #WeCanDoThis
It’s important to discuss treatment options with your doctor if you are pregnant or breastfeeding. The FDA aims to continue improving the information for your medications. https://t.co/QIqF65f5iI
#HealthySkinMonth https://t.co/BBzgS51NYP QT @FDAWomen: Many cosmetics women use daily contain allergens that could cause a reaction in their skin. The FDA has a list of… https://t.co/bdX6EY0aih)